With reference to the above cited subject and our letter dated November 15, 2024, we bring to your kind notice that the Board of Directors of the Company at their meeting held today, i.e. Thursday, November 21, 2024, inter-alia, transacted the following business:1. Pursuant to the recommendations of the Nomination and Remuneration Committee ('NRC'), approved the Vivo Bio Employees Stock Option Scheme, 2024 ('VBESOS, 2024') for grant of stock options to eligible Directors and Employees of the Company and its Group Company(ies) including its Subsidiary / Associate Company(ies) (Present and Future, if any), subject to approval of the shareholders of the Company, as per SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 ['SEBI (SBEBSE) Regulations, 2021']. The Company shall seek the approval of Members through postal ballot.